Vice President of Sales, Joe Ehrline, speaks with Xtalks about the future of clinical trials at the Drug Information Association (DIA) Global Annual Meeting 2019 in San Diego, CA.
“My personal take on the future of clinical trials is on harnessing the data that is out there in clinical trials. Right now, so many companies are struggling with how to incorporate all this data from disparate systems and be able to use that to make business decisions. If you think about it, if you’re only getting partial data, be it from a CRO or EDC system or CTMS system or your financial systems or wherever that data is housed and sitting, how are you able to make informed decisions on partial data? In my mind, it’s like trying to throw darts with a blindfold on. These are decisions that are going to impact the outcome of your trials, it’s going to impact drug development and ultimately it’s going to impact us bringing therapies in need to the patients that are out there.”